Long-term Outcomes after Interventions for Congenital Heart Disease
Long-term Outcomes after Interventions for Congenital Heart Disease
批准号:
10455498
负责人:
Lazaros K. Kochilas
金额:
$82.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-01 至 2024-07-31
关键词:
AddressAdministratorAdultAffectAgeAgingArrhythmiaAwardCardiacCardiac Surgery proceduresCardiovascular systemCaringCause of DeathCessation of lifeCharacteristicsChildChildhoodChildhood Cancer Survivor StudyComplicationDataData FilesData SetData SourcesDevelopmentDiseaseEmploymentExposure toFaceFamilyGeneral PopulationHealthHealth ServicesHealthcareHeart failureInjuryInterventionLesionLifeLinkLongevityMalignant NeoplasmsMedicalModelingMonitorMorbidity - disease rateNeurocognitiveOperative Surgical ProceduresOrganOrgan DonorOrgan TransplantationOutcomePathologyPatient CarePatient-Focused OutcomesPatientsPediatric Surgical ProceduresPersonsPhasePopulationPositioning AttributePremature MortalityProbabilityProceduresPrognostic FactorPublic HealthPulmonary HypertensionQuality of lifeRegistriesResearchResidual stateResourcesRiskSamplingSiblingsSurgical ManagementSurveysSurvivorsTimeTransplantationUnited StatesUpdateVulnerable Populationsbasecare providerscohortcongenital heart disorderevidence basefollow-uphealth care service planningimprovedimproved outcomeindexingmortalitymortality riskorgan procurement transplantation networkpatient engagementpatient orientedpopulation surveypost-transplantprematurepsychosocialresponserisk minimizationrisk stratificationsexsocial relationshipssocioeconomics
中文摘要
项目总结/摘要
先天性心脏病(CHD)影响了近1%的美国(US)出生的儿童,其中许多儿童
他们需要心脏手术以避免死亡或严重发病。外科治疗进展
的冠心病导致冠心病幸存者人数不断增加,目前世界上有200多万冠心病患者。
美国,其中一半以上是成年人。虽然成年后的存活率对于CHD来说是极好的,
对于许多CHD类型的患者,死亡率只是在几十年内发生了变化,现在发生在成年期。
此外,随着年龄的增长,这些患者持续暴露于额外的心血管和非心血管疾病。
心血管疾病的发病率沿着增加,这些疾病的风险可能更高,
预期它们会产生协同损伤,导致额外的过早死亡。重要的是,
众所周知,教育程度,就业和社会关系,其中越来越多的
人口了解长期结果对于确定干预机会和
为这类资源利用率高的人群规划卫生保健服务。
我们的项目旨在填补与冠心病患者长期结局相关的重要空白,
儿科心脏护理联盟(PCCC)是一家大型的美国CHD干预登记中心,
国家死亡指数(NDI)。这种联系使我们能够组成一个队列,描述长期的
冠心病手术患者的死亡率。由于PCCC登记册在规模和范围上是无与伦比的,
该方法提供了美国最强大的数据源,以检查患者的结局轨迹
因CHD手术,现已达到成人年龄。然而,除了死亡率,患者的另一个重要结局是,
CHD的各种干预措施的存活是终末期心力衰竭或肺功能衰竭的发展,
高血压导致需要器官移植。为了解决这个问题,我们补充了
数据集与器官获取和移植网络(OPTN)研究登记处联系,
获得关于在同一队列中进行移植和器官移植的信息。在下一阶段
在我们的项目中,死亡和移植数据都将更新到2021年,以评估与以下相关的特征:
存活率和移植率。此外,作为我们项目的一部分,我们将
调查患者及其兄弟姐妹,以确定疾病对长期医疗的影响,
CHD幸存者与其兄弟姐妹和一般
并确定可能与这些结果相关的相关预后因素
这项研究的完成将提供一个现实和全面的预期结果后,先天性
心脏手术这些信息将对CHD人群的所有相关利益相关者有用,
促进患者及其家属、护理提供者、卫生保健管理人员和公共卫生的参与
改善这一弱势群体的结果。
英文摘要
Project Summary/Abstract
Congenital heart diseases (CHD) affect nearly 1% of children born in the United States (US), with many of
them requiring heart surgery to avoid mortality or significant morbidity. Advances in the surgical management
of CHDs have led to a growing population of CHD survivors, with now over 2 million persons with CHD in the
United States, more than half of whom are adults. While survival to adulthood is now excellent for CHD
patients, for many CHD types the mortality has simply shifted a few decades and now occurs in adulthood.
Moreover, with age, these patients are continuously exposed to additional cardiovascular and non-
cardiovascular morbidities along with the general population, and risk for these morbidities is likely higher as
they are expected to create synergistic injury leading to additional premature mortality. Importantly, little is
known concerning educational attainment, employment, and social relationships among this growing
population. Understanding long-term outcomes is important for identifying opportunities for intervention and
planning for health care services in this population with high resource utilization.
Our project aims to fill important gaps related to the long-term outcomes for patients with CHD by linking the
Pediatric Cardiac Care Consortium (PCCC), a large US-based registry for interventions of CHDs, with the
National Death Index (NDI). This linkage allowed us to constitute a cohort that describes the long-term
mortality of patients with an operated CHD. Since the PCCC registry is unparalleled in its size and scope, this
approach provides the most powerful data source in the US to examine the trajectory of outcomes for patients
operated for CHD now reaching adult age. However, besides mortality another important outcome for patients
surviving various interventions for CHD is the development of end stage cardiac failure or pulmonary
hypertension resulting in the need for organ transplantation. To address this limitation, we supplemented this
dataset with linkage with the Organ Procurement and Transplantation Network (OPTN) research registry to
obtain information regarding listing for transplant and organ transplants in the same cohort. In the next phase
of our project, both death and transplant data will be updated through 2021 to assess characteristics related to
survival and transplant within this aging cohort. In addition, as part of the continuation of our project we will
survey patients and their siblings to determine the effects of the disease on the long-term medical,
neurocognitive, and psychosocial outcomes for survivors of CHD compared to their siblings and the general
population and to identify relevant prognostic factors that may be associated with those outcomes
Completion of this study will provide a realistic and comprehensive view of expected outcomes after congenital
heart surgery. This information will be useful to all relevant stake holders for the population of CHD and will
promote engagement of patients and their families, care providers, health care administrators and public health
officers to improve outcomes in this vulnerable population.
期刊论文(29)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1017/s1047951122000373
发表时间:
2022-02-18
期刊:
CARDIOLOGY IN THE YOUNG
影响因子:
1
作者:
[Tran, Andrew, Kochilas, Lazaros, Thomas, Amanda S., Aggarwal, Varun]
通讯作者:
Aggarwal, Varun
DOI:
10.1016/j.athoracsur.2021.07.053
发表时间:
2022-04
期刊:
ANNALS OF THORACIC SURGERY
影响因子:
4.6
作者:
[Thomas, Amanda S., Chan, Alice, Alsoufi, Bahaaldin, Vinocur, Jeffrey M., Kochilas, Lazaros]
通讯作者:
Kochilas, Lazaros
DOI:
10.1136/heartjnl-2021-319597
发表时间:
2022-05-25
期刊:
Heart (British Cardiac Society)
影响因子:
--
作者:
[Knight JH, Sarvestani AL, Ibezim C, Turk E, McCracken CE, Alsoufi B, St Louis J, Moller JH, Raghuveer G, Kochilas LK]
通讯作者:
Kochilas LK
DOI:
10.1016/j.jpeds.2021.08.034
发表时间:
2021-12
期刊:
The Journal of pediatrics
影响因子:
--
作者:
[Alam S, Claxton JS, Mortillo M, Sassis L, Kefala-Karli P, Silberbach M, Kochilas L, Wechsler SB]
通讯作者:
Wechsler SB
DOI:
10.1016/j.jpeds.2020.12.058
发表时间:
2021-04
期刊:
The Journal of pediatrics
影响因子:
--
作者:
[Peterson JK, Kochilas LK, Knight J, McCracken C, Thomas AS, Moller JH, Setty SP]
通讯作者:
Setty SP
共 14 条
Long-term outcomes in patients with single ventricle physiology
-
批准号:9883836
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2019
-
负责人:Lazaros K. Kochilas
-
依托单位:
Long-term Outcomes after Interventions for Congenital Heart Disease
-
批准号:10219333
-
项目类别:
-
资助金额:$102.96万
-
财政年份:2014
-
负责人:Lazaros K. Kochilas
-
依托单位:
Long-term Outcomes after Interventions for Congenital Heart Disease
-
批准号:9981776
-
项目类别:
-
资助金额:$96.47万
-
财政年份:2014
-
负责人:Lazaros K. Kochilas
-
依托单位:
All Cause Mortality 1-30 Years After Interventions for Congenital Heart Diseases
-
批准号:8670521
-
项目类别:
-
资助金额:$65.82万
-
财政年份:2014
-
负责人:Lazaros K. Kochilas
-
依托单位:
All Cause Mortality 1-30 Years After Interventions for Congenital Heart Diseases
-
批准号:9241438
-
项目类别:
-
资助金额:$23.35万
-
财政年份:2014
-
负责人:Lazaros K. Kochilas
-
依托单位:
All Cause Mortality 1-30 Years After Interventions for Congenital Heart Diseases
-
批准号:9096979
-
项目类别:
-
资助金额:$24.3万
-
财政年份:2014
-
负责人:Lazaros K. Kochilas
-
依托单位:
COBRE: WI HOSP OF RI: P57KIP2 IN VENTRICULAR CARDIOMYOCYTE DIFFERENTIATION
-
批准号:7720720
-
项目类别:
-
资助金额:$29.66万
-
财政年份:2008
-
负责人:Lazaros K. Kochilas
-
依托单位:
COBRE: WI HOSP OF RI: P57KIP2 IN VENTRICULAR CARDIOMYOCYTE DIFFERENTIATION
-
批准号:7610523
-
项目类别:
-
资助金额:$21.98万
-
财政年份:2007
-
负责人:Lazaros K. Kochilas
-
依托单位:
COBRE: WI HOSP OF RI: P57KIP2 IN VENTRICULAR CARDIOMYOCYTE DIFFERENTIATION
-
批准号:7381990
-
项目类别:
-
资助金额:$23.15万
-
财政年份:2006
-
负责人:Lazaros K. Kochilas
-
依托单位:
The Role of HDAC3 in Cardiac Growth and Development
-
批准号:7143835
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2006
-
负责人:Lazaros K. Kochilas
-
依托单位:
"The Role of HDAC3 in Cardiac Growth and Development"
-
批准号:7251476
-
项目类别:
-
资助金额:$7.28万
-
财政年份:2006
-
负责人:Lazaros K. Kochilas
-
依托单位:
COBRE: WI HOSP OF RI: P57KIP2 IN VENTRICULAR CARDIOMYOCYTE DIFFERENTIATION
-
批准号:7171211
-
项目类别:
-
资助金额:$20.6万
-
财政年份:2005
-
负责人:Lazaros K. Kochilas
-
依托单位:
COBRE: WI HOSP OF RI: P57KIP2 IN VENTRICULAR CARDIOMYOCYTE DIFFERENTIATION
-
批准号:6981886
-
项目类别:
-
资助金额:$24.54万
-
财政年份:2004
-
负责人:Lazaros K. Kochilas
-
依托单位:
Neural Crest and Cardiac Outflow Tract Formation
-
批准号:6333477
-
项目类别:
-
资助金额:$12.37万
-
财政年份:2000
-
负责人:Lazaros K. Kochilas
-
依托单位:
Neural Crest and Cardiac Outflow Tract Formation
-
批准号:6799198
-
项目类别:
-
资助金额:$12.17万
-
财政年份:2000
-
负责人:Lazaros K. Kochilas
-
依托单位:
Neural Crest and Cardiac Outflow Tract Formation
-
批准号:6653909
-
项目类别:
-
资助金额:$12.17万
-
财政年份:2000
-
负责人:Lazaros K. Kochilas
-
依托单位:
Neural Crest and Cardiac Outflow Tract Formation
-
批准号:6528005
-
项目类别:
-
资助金额:$12.17万
-
财政年份:2000
-
负责人:Lazaros K. Kochilas
-
依托单位:
Neural Crest and Cardiac Outflow Tract Formation
-
批准号:6541992
-
项目类别:
-
资助金额:$12.17万
-
财政年份:2000
-
负责人:Lazaros K. Kochilas
-
依托单位:
海外基金